Get the app!
Back to Trades

Degnan Chris

Chief Financial OfficerCIK 0001741968

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
2
Companies
1
Active
2025–2026

Degnan Chris, Chief Financial Officer, accounts for 3 disclosed filings worth $117.9K, all concentrated in UroGen Pharma Ltd. (URGN), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $117.9K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Oct 9URGN
UroGen Pharma Ltd.
Degnan ChrisChief Financial OfficerSell$80.8K
Feb 3URGN
UroGen Pharma Ltd.
Degnan ChrisChief Financial OfficerAward$0
Oct 9URGN
UroGen Pharma Ltd.
Degnan ChrisChief Financial OfficerSell$37.1K

3 filings